Stock listing
SRZN Stock Price, News, Filings & Events — Surrozen, Inc.
Selected listing: SRZN · NASDAQ · USD · US
This page tracks Surrozen, Inc.'s SRZN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SRZN:NASDAQ. SRZN:NASDAQ is the stock-level entry point for investors researching Surrozen, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Surrozen, Inc. is a public company traded under the ticker SRZN in the American market. The company has a market capitalization of approximately $229 million. Surrozen focuses on developing innovative therapies to address unmet medical needs.

- Ticker
- SRZN:NASDAQ
- Asset type
- Stock
- Market cap
- $223.3M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD
Surrozen, Inc. SRZN:NASDAQ stock context
This page tracks Surrozen, Inc.'s SRZN:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following SRZN:NASDAQ. SRZN:NASDAQ is the stock-level entry point for investors researching Surrozen, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Surrozen, Inc. is a public company traded under the ticker SRZN in the American market. The company has a market capitalization of approximately $229 million. Surrozen focuses on developing innovative therapies to address unmet medical needs.
Latest news from Surrozen, Inc.
Surrozen Announces Submission of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
September 8, 2026
Surrozen : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)
August 6, 2026
Surrozen Reports Second Quarter 2026 Financial Results and Provides Business Update
August 6, 2026
Surrozen Reports First Quarter 2026 Financial Results and Provides Business Update
May 6, 2026
Surrozen Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update
March 23, 2026
Surrozen, Inc. earnings calls
Research Surrozen, Inc.
Surrozen, Inc. investor report
Review AI stock analysis and investor report context for SRZN:NASDAQ.
Surrozen, Inc. company profile
View the public company page for Surrozen, Inc. on 6ix.
Surrozen, Inc. news
Read company news and market updates connected to Surrozen, Inc..
Surrozen, Inc. investor events
Find investor webinars, events, and replay context for Surrozen, Inc..